VHL and renal cell carcinoma: Taken together these analyses suggest that RCC-susceptibility polymorphisms extend beyond those currently defined as significant in GWAS, and that at least part of this susceptibility is mediated by polymorphisms that impinge on the VHL/HIF pathway.